Anosmia was identified as a hallmark of COVID-19 early in the pandemic, however, with the
emergence of variants of concern, the clinical profile induced by SARS-CoV-2 infection has …

Historical epidemiological perspectives from past pandemics and recent neurobiological
evidence link infections and psychoses, leading to concerns that COVID-19 will present a …

Ms. Priyanka Nagu is a M. Pharm in Pharmaceutics and is currently pursuing her PhD in
neuroscience. Her area of interest includes the understanding of the pathogenesis and …

In some patients, COVID-19 can trigger neurological symptoms with unclear pathogenesis.
Here we describe a microphysiological system integrating alveolus and blood–brain barrier …

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative
agent of coronavirus disease 2019 (COVID-19), which was rapidly declared a pandemic by …

Neuropsychiatric manifestations are common in both the acute and post-acute phase of
SARS-CoV-2 infection, but the mechanisms of these effects are unknown. In a newly …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the cause of a
present pandemic, infects human lung alveolar type 2 (hAT2) cells. Characterizing …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has caused large-scale
economic and social losses and worldwide deaths. Although most COVID-19 patients have …

As new pathogens emerge, new challenges must be faced. This is no different in infectious
disease research, where identifying the best tools available in laboratories to conduct an …